Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium
- PMID: 32756879
 - PMCID: PMC7403757
 - DOI: 10.1093/infdis/jiaa394
 
Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium
Abstract
In recent years, the global public health community has increasingly recognized the importance of antimicrobial stewardship (AMS) in the fight to improve outcomes, decrease costs, and curb increases in antimicrobial resistance around the world. However, the subject of antifungal stewardship (AFS) has received less attention. While the principles of AMS guidelines likely apply to stewarding of antifungal agents, there are additional considerations unique to AFS and the complex field of fungal infections that require specific recommendations. In this article, we review the literature on AMS best practices and discuss AFS through the lens of the global core elements of AMS. We offer recommendations for best practices in AFS based on a synthesis of this evidence by an interdisciplinary expert panel of members of the Mycoses Study Group Education and Research Consortium. We also discuss research directions in this rapidly evolving field. AFS is an emerging and important component of AMS, yet requires special considerations in certain areas such as expertise, education, interventions to optimize utilization, therapeutic drug monitoring, and data analysis and reporting.
Keywords: antifungal; aspergillosis; candidiasis; diagnostics; guidelines; stewardship.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Comment in
- 
  
  Should Routine Eye Examinations Be Included in Treatment Bundles for Patients with Candidemia?J Infect Dis. 2021 Nov 16;224(9):1626-1627. doi: 10.1093/infdis/jiab182. J Infect Dis. 2021. PMID: 33822105 No abstract available.
 
References
- 
    
- des Champs-Bro B, Leroy-Cotteau A, Mazingue F, et al. . Invasive fungal infections: epidemiology and analysis of antifungal prescriptions in onco-haematology. J Clin Pharm Ther 2011; 36:152–60. - PubMed
 
 - 
    
- Muñoz P, Valerio M, Vena A, Bouza E. Antifungal stewardship in daily practice and health economic implications. Mycoses 2015; 58(Suppl 2):14–25. - PubMed
 
 - 
    
- Valerio M, Rodriguez-Gonzalez CG, Muñoz P, Caliz B, Sanjurjo M, Bouza E; COMIC Study Group (Collaborative Group on Mycoses) Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently needed. J Antimicrob Chemother 2014; 69:1993–9. - PubMed
 
 - 
    
- Azoulay E, Dupont H, Tabah A, et al. . Systemic antifungal therapy in critically ill patients without invasive fungal infection. Crit Care Med 2012; 40:813–22. - PubMed
 
 
